USANA Health Sciences (USNA) Tops Q2 EPS by 32c

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.92, $0.32 better than the analyst estimate of $1.60. Revenue for the quarter came in at $233.2 million versus the consensus estimate of $212.94 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• DA Davidson Assumes Knife River Corp. (KNF) at Buy
• Five Below ’priced for perfection’, says Loop Capital
• SelectQuote, Inc. (SLQT) Misses Q4 EPS by 4c ; Offers Guidance